IL99123A0 - Pharmaceutical compositions for treatment of bone wasting diseases,comprising estrogen derivatives - Google Patents
Pharmaceutical compositions for treatment of bone wasting diseases,comprising estrogen derivativesInfo
- Publication number
- IL99123A0 IL99123A0 IL99123A IL9912391A IL99123A0 IL 99123 A0 IL99123 A0 IL 99123A0 IL 99123 A IL99123 A IL 99123A IL 9912391 A IL9912391 A IL 9912391A IL 99123 A0 IL99123 A0 IL 99123A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- pharmaceutical compositions
- wasting diseases
- estrogen derivatives
- bone wasting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56576390A | 1990-08-10 | 1990-08-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL99123A0 true IL99123A0 (en) | 1992-07-15 |
Family
ID=24259992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL99123A IL99123A0 (en) | 1990-08-10 | 1991-08-08 | Pharmaceutical compositions for treatment of bone wasting diseases,comprising estrogen derivatives |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0474374A1 (fr) |
JP (1) | JPH04230632A (fr) |
KR (1) | KR930003924A (fr) |
AU (1) | AU8166191A (fr) |
CA (1) | CA2048810A1 (fr) |
FI (1) | FI913791A (fr) |
HU (1) | HUT59605A (fr) |
IE (1) | IE912832A1 (fr) |
IL (1) | IL99123A0 (fr) |
NO (1) | NO913117L (fr) |
PT (1) | PT98626A (fr) |
ZA (1) | ZA916317B (fr) |
ZW (1) | ZW11391A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA94715B (en) * | 1993-02-08 | 1994-10-24 | Akzo Nv | Steroids for treating menopausal complaints |
US5710144A (en) * | 1993-02-08 | 1998-01-20 | Akzo Nobel N.V. | C-11 substituted steroids for treating menopausal complaints |
US6037339A (en) | 1993-02-08 | 2000-03-14 | Akzo Nobel N.V. | C-11 substituted steroids for treating menopausal complaints |
IL120265A0 (en) * | 1996-02-28 | 1997-06-10 | Pfizer | Combination therapy to treat osteoporosis - polyphosphonates or progestins and estrogen agonists |
DE19815060A1 (de) * | 1998-04-03 | 1999-10-14 | Jenapharm Gmbh | Pharmazeutische Präparate zur Therapie von Nebenwirkungen während und/oder nach einer GnRHa-Therapie |
AU2223600A (en) * | 1999-01-06 | 2000-07-24 | Cedars-Sinai Medical Center | Hormone replacement for breast cancer patients |
AU2003234637B2 (en) * | 2002-05-24 | 2009-04-30 | The Trustees Of The University Of Pennsylvania | Methods and compositions for inhibiting HIV replication |
KR101586336B1 (ko) * | 2014-08-06 | 2016-01-18 | 한국생명공학연구원 | 에스트로피페이트(Estropipate) 또는 이의 약학적으로 허용 가능한 염을 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물 |
JP7154616B2 (ja) * | 2017-06-01 | 2022-10-18 | ネクシオン バイオテック カンパニー リミテッド | 骨関連疾患の予防または治療のための薬学組成物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0559240B1 (fr) * | 1987-09-24 | 2001-12-05 | Jencap Research Limited | Packages contraceptives contenant de l'estrogen et du progestin |
HUT52382A (en) * | 1988-03-14 | 1990-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case |
-
1991
- 1991-08-06 AU AU81661/91A patent/AU8166191A/en not_active Abandoned
- 1991-08-08 JP JP3222396A patent/JPH04230632A/ja active Pending
- 1991-08-08 HU HU912646A patent/HUT59605A/hu unknown
- 1991-08-08 IL IL99123A patent/IL99123A0/xx unknown
- 1991-08-08 CA CA002048810A patent/CA2048810A1/fr not_active Abandoned
- 1991-08-09 ZW ZW113/91A patent/ZW11391A1/xx unknown
- 1991-08-09 ZA ZA916317A patent/ZA916317B/xx unknown
- 1991-08-09 PT PT98626A patent/PT98626A/pt not_active Application Discontinuation
- 1991-08-09 KR KR1019910013737A patent/KR930003924A/ko not_active Application Discontinuation
- 1991-08-09 EP EP91307335A patent/EP0474374A1/fr not_active Withdrawn
- 1991-08-09 FI FI913791A patent/FI913791A/fi unknown
- 1991-08-09 NO NO91913117A patent/NO913117L/no unknown
- 1991-08-09 IE IE283291A patent/IE912832A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT98626A (pt) | 1992-06-30 |
FI913791A (fi) | 1992-02-11 |
ZW11391A1 (en) | 1993-04-07 |
HU912646D0 (en) | 1992-01-28 |
CA2048810A1 (fr) | 1992-02-11 |
NO913117D0 (no) | 1991-08-09 |
NO913117L (no) | 1992-02-11 |
ZA916317B (en) | 1993-04-28 |
AU8166191A (en) | 1992-02-13 |
HUT59605A (en) | 1992-06-29 |
EP0474374A1 (fr) | 1992-03-11 |
JPH04230632A (ja) | 1992-08-19 |
FI913791A0 (fi) | 1991-08-09 |
KR930003924A (ko) | 1993-03-22 |
IE912832A1 (en) | 1992-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9701694A3 (en) | Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds | |
HUP9600211A3 (en) | Heterocyclic compounds, process for producing them and pharmaceutical compositions containing them, as an activ ingredient | |
HUT70034A (en) | Process for preparing pharmaceutical compositions containing dipyridamole for the treatment of proliferative diseases | |
ZA916583B (en) | 3-amidopyrazole derivatives,process for preparing these and pharmaceutical compositions containing them | |
HUT72639A (en) | Substituted thiazolidinedione derivatives, pharmaceutical compositions containing them and process for their preparation | |
HUP9601033A3 (en) | Benzofurane derivatives, process for their preparation, use of them as intermediate and pharmaceutical compositions containing the compounds | |
HUP9900386A3 (en) | Use of phenoxy-pyridine derivatives for producing pharmaceutical compositions suitable for treating heart failure | |
ZA983602B (en) | Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination | |
HUP9901326A3 (en) | Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions | |
AU6858996A (en) | Pharmaceutical compositions for the treatment of infectious diseases | |
HUP9904317A3 (en) | Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases | |
IL99123A0 (en) | Pharmaceutical compositions for treatment of bone wasting diseases,comprising estrogen derivatives | |
HUP9802393A3 (en) | Benzothiazolone derivatives, their use, pharmaceutical compositions containing them, process for the preparation thereof and intermediates | |
GR3034582T3 (en) | Substituted 4-phenyl thiazole derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP9903103A3 (en) | Use of a pleuromutilin derivative for the preparation of pharmaceutical compositions treating veterinary diseases caused by increasing stocking density | |
EP0558961A3 (en) | Glycopeptide derivatives, process for their manufacture and pharmaceutical compositions comprising them | |
HU900746D0 (en) | Process for preparation of 2,3,23-trihydroxy-urz-12-en and it's derivatives and for pharmaceutical compositions containing that compounds | |
HUP0000954A3 (en) | Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy | |
HUP9901680A3 (en) | Use of piperazin-, piperidin- or hexahidropiridazin derivatives for the preparation of pharmaceutical compositions, new piperazin derivatives and pharmaceutical compositions containing these compounds | |
HUP0202371A3 (en) | Diacylhydrazine derivatives, process for producing them, use of these derivatives for producing of pharmaceutical compositions and pharmaceutical compositions | |
ZA977874B (en) | Pharmaceutical compositions for treating viral diseases | |
HUP9602324A3 (en) | Piperidinyl-methyl-oxazolidinon derivatives, pharmaceutical compositions containing the same, process for the preparation of the compounds and use of them | |
HUP9801925A3 (en) | Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions treating diseases caused by protozoons | |
IL130831A (en) | Imino-aza-anthrayclinone derivatives, process for their preparation and pharmaceutical compositions comprising them for the treatment of amyloidosis | |
IL109235A0 (en) | Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases |